Captis Biotechnology, Inc. is a diagnostics company with the mission of commercializing discoveries that address major challenges in disease and pharmaceutical detection and monitoring. The technologies developed by Captis research and diagnostics are towards the treatment of chronic diseases such as cancer, cardiovascular and Alzheimer’s.
Robert M. Strongin, Ph.D.
CEO & President
Dr. Strongin is an Organic Chemist and a Professor in the Chemistry Department at Portland State University and CSO of Elex Biotech, Inc. He is the inventor of fifteen patents, published three books and authored 130 peer-reviewed publications. He is a former medicinal chemist at SmithKline Beecham (now GlaxoSmithKline). He holds a Ph.D. from the University of Pennsylvania (Organic Chemistry) and a BS from Temple University (Chemistry, Honors).
Dr. Robert M. Strongin
2828 SW Corbett Avenue Suite 211A
Portland, OR, 97201, USA